Page last updated: 2024-10-22

amobarbital and Cephalgia, Vascular

amobarbital has been researched along with Cephalgia, Vascular in 3 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guthy, H1
Hildgen, J1
Brinkmann, G1
Sabbagh, M1
Gerbold, H1

Other Studies

3 other studies available for amobarbital and Cephalgia, Vascular

ArticleYear
[Treatment of vascular headache].
    Medizinische Monatsschrift, 1969, Volume: 23, Issue:9

    Topics: Adult; Amobarbital; Caffeine; Codeine; Ergotamine; Female; Headache; Humans; Male; Middle Aged; Phen

1969
[Therapy of the vasomotor headache in childhood].
    Medizinische Monatsschrift, 1970, Volume: 24, Issue:9

    Topics: Adolescent; Amines; Amobarbital; Caffeine; Child; Child, Preschool; Codeine; Ergotamine; Headache; H

1970
[Treatment of vascular headaches with a new compound preparation].
    Zeitschrift fur Allgemeinmedizin, 1970, Feb-28, Volume: 46, Issue:6

    Topics: Acetaminophen; Adult; Amobarbital; Analgesics; Caffeine; Codeine; Ergotamine; Female; Headache; Huma

1970